In silico and in vitro assessment of natural compounds and derivatives as novel anti-amyloid drugs

Project funded by Fundação para a Ciência e a Tecnologia, I.P. (FCT) (CEEC IND 2018), grant CEECIND/02017/2018/CP1545/CT0002. Funded amount: EUR 229,849, as stated by the source. Runs 2020-06-01 to 2026-05-31. Keywords: AMYLIN MISFOLDING, TYPE 2 DIABETES, QUANTUM MECHANICS/MOLECULAR MECHANICS (QM/MM) METHODS, TRANSITION PATH SAMPLING, CELLULAR ASSAYS. Source: OpenAIRE Graph, from the funder's project data (collected by OpenAIRE on 2025-07-21); national funding data, not CORDIS; selected because its keywords name quantum.

Original source.

Source: OpenAIRE Graph: projects of national funders, OpenAIRE, from the project data of Fundação para a Ciência e a Tecnologia, I.P. (FCT). Retrieved 2026-10-28. Licence: Creative Commons Attribution 4.0 (OpenAIRE Graph). Selected metadata, adapted presentation; the publisher's record is authoritative. No endorsement by the source is implied. Licence: Creative Commons Attribution 4.0 (CC BY 4.0).

AI-assisted summary: The project titled 'In silico and in vitro assessment of natural compounds and derivatives as novel anti-amyloid drugs' is funded by FCT with a grant of EUR 229,849, running from June 1, 2020, to May 31, 2026. It focuses on amyloid misfolding and type 2 diabetes using QM/MM methods. Suggested technology pillar: simulation. Generated by AI from the public source text; it may contain errors and the original source is authoritative.